-- dump date   	20240514_082631
-- class       	Genbank::Contig
-- table       	contig_comment
-- id	comment
NW_004443936.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443935.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443805.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443803.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443801.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443934.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443799.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443797.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443795.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443933.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443932.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443793.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443791.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443931.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443789.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443930.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443929.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443928.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443927.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443787.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443785.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443926.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443783.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443925.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443781.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443924.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443779.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443777.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443923.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443922.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443921.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443920.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443919.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443918.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443775.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443917.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443773.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443916.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443915.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443914.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443913.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443912.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443911.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443770.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443767.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443910.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443909.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443908.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443907.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443765.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443763.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443906.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443905.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443904.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443903.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443761.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443759.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443757.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443755.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443753.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443751.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443902.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443901.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443900.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443750.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443747.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443899.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443898.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443746.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443897.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443744.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443896.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443895.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443742.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443740.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443894.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443738.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443893.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443736.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443892.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443734.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443891.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443732.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443890.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443889.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443730.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443728.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443726.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443724.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443723.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443720.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443717.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443715.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443888.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443887.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443886.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443713.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443885.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443884.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443883.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443882.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443881.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443711.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443880.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443709.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443879.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443878.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443707.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443877.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443876.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443705.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443875.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443703.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443874.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443873.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443872.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443871.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443701.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443870.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443699.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443696.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443869.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443868.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443692.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443867.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443690.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443866.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443688.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443865.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443685.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443684.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443864.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443681.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443680.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443863.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443862.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443861.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443678.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443860.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443859.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443858.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443857.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443675.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443856.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443674.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206269. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443672.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206270. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443855.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206271. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443670.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206272. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443668.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206273. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443854.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206274. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443853.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206275. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443852.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206276. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443851.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206277. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443850.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206278. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443849.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206279. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443666.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206280. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443664.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206281. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443662.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206282. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443660.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206283. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443658.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206284. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443848.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206285. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443847.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206286. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443846.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206287. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443845.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206288. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443656.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206289. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443844.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206290. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443654.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206291. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443648.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206292. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443843.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206293. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443647.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206294. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443645.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206295. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443643.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206296. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443842.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206297. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443640.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206298. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443841.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206299. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443840.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206300. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443839.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206301. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443838.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206302. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443837.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206303. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443836.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206304. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443638.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206305. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443835.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206306. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443636.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206307. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443834.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206308. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443634.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206309. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443632.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206310. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443833.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206311. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443630.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206312. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443832.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206313. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443628.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206314. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443626.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206315. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443831.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206316. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443830.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206317. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443829.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206318. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443828.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206319. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443623.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206320. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443827.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206321. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443826.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206322. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443825.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206323. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443824.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206324. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443621.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206325. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443619.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206326. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443823.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206327. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443822.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206328. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443821.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206329. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443820.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206330. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443617.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206331. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443615.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206332. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443819.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206333. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443613.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206334. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443611.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206335. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443608.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206336. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443606.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206337. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443818.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206338. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443817.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206339. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443604.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206340. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443816.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206341. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443602.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206342. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443815.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206343. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443814.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206344. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443813.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206345. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443812.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206346. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443600.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206347. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443811.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206348. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443810.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206349. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443809.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206350. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443808.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206351. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443807.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206352. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443598.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206353. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443806.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206354. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443804.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206355. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443595.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206356. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443802.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206357. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443593.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206358. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443591.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206359. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443800.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206360. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443589.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206361. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443798.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206362. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443587.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206363. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443585.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206364. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443583.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206365. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443580.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206366. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443796.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206367. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443578.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206368. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443576.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206369. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443794.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206370. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443573.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206371. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443571.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206372. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443569.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206373. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443792.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206374. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443790.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206375. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443788.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206376. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443786.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206377. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443568.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206378. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443566.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206379. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443563.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206380. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443784.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206381. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443782.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206382. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443561.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206383. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443780.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206384. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443778.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206385. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443776.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206386. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443559.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206387. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443774.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206388. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443772.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206389. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443771.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206390. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443556.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206391. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443769.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206392. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443554.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206393. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443768.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206394. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443552.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206395. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443766.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206396. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443550.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206397. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443547.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206398. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443545.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206399. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443764.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206400. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443543.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206401. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443762.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206402. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443760.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206403. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443541.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206404. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443758.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206405. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443539.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206406. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443756.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206407. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443754.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206408. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443752.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206409. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443749.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206410. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443536.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206411. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443748.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206412. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443745.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206413. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443743.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206414. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443741.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206415. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443534.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206416. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443739.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206417. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443737.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206418. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443735.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206419. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443733.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206420. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443533.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206421. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443731.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206422. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443729.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206423. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443727.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206424. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443531.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206425. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443725.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206426. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443722.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206427. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443529.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206428. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443721.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206429. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443719.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206430. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443718.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206431. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443716.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206432. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443527.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206433. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443525.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206434. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443714.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206435. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443712.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206436. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443710.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206437. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443708.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206438. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443706.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206439. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443523.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206440. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443704.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206441. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443702.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206442. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443700.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206443. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443698.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206444. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443697.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206445. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443520.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206446. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443695.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206447. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443694.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206448. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443693.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206449. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443518.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206450. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443515.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206451. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443691.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206452. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443689.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206453. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443513.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206454. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443511.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206455. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443687.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206456. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443509.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206457. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443506.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206458. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443686.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206459. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443504.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206460. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443683.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206461. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440455.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206462. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440453.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206463. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443682.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206464. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443679.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206465. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443677.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206466. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440451.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206467. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443676.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206468. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440449.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206469. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443673.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206470. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443671.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206471. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443669.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206472. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443667.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206473. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440445.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206474. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440443.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206475. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443665.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206476. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443663.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206477. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443661.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206478. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440440.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206479. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443659.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206480. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440438.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206481. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440436.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206482. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440432.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206483. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440426.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206484. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443657.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206485. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443655.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206486. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440424.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206487. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443653.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206488. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440422.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206489. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443652.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206490. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440419.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206491. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443651.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206492. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443650.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206493. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443649.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206494. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443646.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206495. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443644.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206496. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443642.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206497. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443641.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206498. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443639.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206499. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440417.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206500. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440415.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206501. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443637.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206502. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443635.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206503. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443633.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206504. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440413.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206505. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440411.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206506. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443631.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206507. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440409.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206508. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443629.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206509. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440407.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206510. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440406.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206511. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440403.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206512. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443627.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206513. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440401.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206514. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443625.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206515. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440399.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206516. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443624.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206517. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443622.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206518. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443620.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206519. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443618.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206520. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443616.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206521. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443614.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206522. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443612.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206523. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443610.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206524. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440397.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206525. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440395.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206526. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440393.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206527. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440391.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206528. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440389.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206529. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443609.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206530. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443607.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206531. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440387.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206532. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443605.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206533. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443603.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206534. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443601.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206535. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443599.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206536. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440383.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206537. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440380.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206538. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443597.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206539. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443596.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206540. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443594.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206541. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440378.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206542. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443592.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206543. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443590.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206544. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440376.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206545. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443588.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206546. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440373.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206547. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443586.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206548. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443584.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206549. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440371.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206550. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443582.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206551. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443581.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206552. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443579.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206553. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443577.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206554. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440369.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206555. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443575.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206556. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443574.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206557. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443572.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206558. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440367.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206559. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443570.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206560. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443567.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206561. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443565.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206562. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440365.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206563. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443564.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206564. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440363.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206565. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443562.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206566. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443560.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206567. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440361.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206568. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443558.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206569. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443557.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206570. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440359.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206571. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443555.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206572. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440356.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206573. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443553.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206574. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443551.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206575. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443549.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206576. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440354.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206577. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443548.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206578. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443546.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206579. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443544.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206580. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443542.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206581. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443540.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206582. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443538.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206583. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443537.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206584. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440352.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206585. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443535.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206586. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440350.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206587. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443532.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206588. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440347.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206589. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440345.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206590. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440343.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206591. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440342.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206592. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443530.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206593. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440339.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206594. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440337.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206595. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440335.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206596. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443528.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206597. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443526.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206598. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443524.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206599. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443522.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206600. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440333.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206601. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443521.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206602. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443519.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206603. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440331.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206604. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443517.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206605. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443516.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206606. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440329.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206607. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440327.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206608. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440325.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206609. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443514.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206610. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443512.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206611. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443510.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206612. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440323.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206613. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443508.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206614. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443507.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206615. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440321.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206616. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004443505.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206617. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440456.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206618. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440454.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206619. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440319.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206620. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440317.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206621. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440452.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206622. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440450.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206623. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440448.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206624. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440315.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206625. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440313.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206626. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440447.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206627. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440311.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206628. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440309.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206629. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440307.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206630. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440446.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206631. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440305.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206632. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440444.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206633. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440442.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206634. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440441.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206635. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440439.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206636. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440437.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206637. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440435.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206638. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440434.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206639. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440433.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206640. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440431.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206641. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440430.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206642. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440304.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206643. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440302.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206644. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440429.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206645. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440428.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206646. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440300.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206647. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440427.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206648. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440425.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206649. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440423.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206650. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440421.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206651. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440298.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206652. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440420.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206653. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440418.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206654. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440416.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206655. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440414.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206656. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440296.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206657. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440412.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206658. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440410.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206659. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440294.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206660. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440408.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206661. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440405.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206662. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440404.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206663. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440291.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206664. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440289.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206665. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440402.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206666. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440400.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206667. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440398.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206668. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440396.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206669. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440286.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206670. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440394.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206671. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440284.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206672. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440283.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206673. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440392.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206674. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440390.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206675. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440388.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206676. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440386.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206677. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440280.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206678. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440278.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206679. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440277.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206680. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440274.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206681. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440273.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206682. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440271.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206683. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440269.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206684. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440267.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206685. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440385.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206686. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440265.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206687. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440384.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206688. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440263.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206689. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440261.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206690. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440382.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206691. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440381.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206692. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440259.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206693. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440257.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206694. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440379.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206695. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440377.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206696. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440255.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206697. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440375.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206698. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440374.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206699. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440253.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206700. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440250.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206701. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440248.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206702. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440247.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206703. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440245.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206704. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440372.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206705. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440243.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206706. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440240.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206707. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440238.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206708. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440236.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206709. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440370.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206710. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440368.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206711. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440366.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206712. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440234.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206713. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440364.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206714. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440362.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206715. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440233.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206716. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440231.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206717. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440230.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206718. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440360.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206719. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440358.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206720. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440228.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206721. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440225.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206722. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440357.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206723. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440223.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206724. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440222.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206725. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440355.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206726. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440353.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206727. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440220.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206728. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440351.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206729. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440349.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206730. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440217.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206731. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440348.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206732. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440215.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206733. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440346.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206734. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440344.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206735. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440341.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206736. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440213.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206737. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440211.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206738. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440209.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206739. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440207.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206740. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440340.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206741. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440206.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206742. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440338.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206743. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440203.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206744. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440336.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206745. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440334.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206746. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440201.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206747. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440332.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206748. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440330.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206749. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440199.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206750. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440197.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206751. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440328.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206752. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440326.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206753. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440195.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206754. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440193.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206755. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440189.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206756. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440187.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206757. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440324.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206758. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440186.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206759. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440322.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206760. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440320.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206761. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440318.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206762. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440184.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206763. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440316.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206764. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440314.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206765. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440312.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206766. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440310.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206767. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440308.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206768. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440306.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206769. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440303.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206770. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440182.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206771. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440180.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206772. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440178.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206773. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440176.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206774. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440301.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206775. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440299.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206776. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440173.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206777. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440297.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206778. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440295.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206779. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440293.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206780. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440172.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206781. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440292.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206782. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440169.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206783. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440168.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206784. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440290.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206785. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440288.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206786. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440165.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206787. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440163.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206788. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440287.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206789. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440161.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206790. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440160.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206791. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440157.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206792. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440285.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206793. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440282.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206794. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440155.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206795. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440281.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206796. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440153.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206797. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440151.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206798. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440279.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206799. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440276.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206800. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440150.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206801. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440275.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206802. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440272.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206803. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440270.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206804. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440268.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206805. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440266.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206806. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440264.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206807. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440262.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206808. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440260.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206809. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440258.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206810. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440256.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206811. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440254.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206812. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440252.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206813. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440251.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206814. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440148.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206815. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440249.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206816. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440146.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206817. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440144.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206818. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440246.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206819. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440244.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206820. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440242.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206821. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440241.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206822. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440239.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206823. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440237.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206824. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440141.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206825. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440140.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206826. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440138.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206827. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440235.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206828. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440232.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206829. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440135.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206830. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440229.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206831. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440227.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206832. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440226.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206833. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440134.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206834. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440132.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206835. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440224.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206836. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440130.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206837. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440221.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206838. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440128.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206839. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440125.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206840. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440219.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206841. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440124.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206842. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440121.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206843. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440218.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206844. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440119.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206845. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440118.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206846. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440117.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206847. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440216.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206848. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440214.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206849. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440212.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206850. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440210.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206851. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440116.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206852. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440208.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206853. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440115.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206854. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440205.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206855. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440204.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206856. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440114.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206857. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440202.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206858. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440200.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206859. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440113.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206860. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440198.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206861. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440112.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206862. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440196.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206863. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440111.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206864. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440110.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206865. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440194.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206866. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440192.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206867. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440109.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206868. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440108.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206869. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440191.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206870. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440190.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206871. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440107.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206872. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440188.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206873. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440185.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206874. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440106.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206875. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440183.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206876. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440181.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206877. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440179.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206878. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440177.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206879. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440105.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206880. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440104.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206881. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440103.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206882. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440102.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206883. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440175.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206884. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440174.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206885. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440101.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206886. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440171.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206887. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440170.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206888. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440167.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206889. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440100.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206890. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440099.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206891. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440098.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206892. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440097.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206893. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440166.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206894. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440164.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206895. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440096.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206896. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440162.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206897. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440159.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206898. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440158.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206899. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440156.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206900. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440154.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206901. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440095.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206902. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440152.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206903. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440094.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206904. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440149.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206905. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440093.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206906. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440092.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206907. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440147.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206908. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440091.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206909. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440145.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206910. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440143.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206911. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440142.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206912. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440139.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206913. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440090.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206914. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440089.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206915. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440137.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206916. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440136.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206917. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440088.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206918. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440087.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206919. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440133.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206920. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440131.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206921. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440129.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206922. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440086.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206923. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440127.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206924. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440126.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206925. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440123.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206926. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440122.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206927. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440085.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206928. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440120.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206929. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440084.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206930. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440083.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206931. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004440082.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206932. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191929.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206933. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191928.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206934. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191927.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206935. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191926.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206936. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191925.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206937. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191924.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206938. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191923.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206939. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191922.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206940. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191921.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206941. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191920.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206942. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191919.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206943. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191918.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206944. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191917.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206945. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191916.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206946. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191915.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206947. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191914.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206948. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191913.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206949. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191912.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206950. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191911.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206951. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191910.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206952. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191909.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206953. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191908.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206954. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191907.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206955. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191906.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206956. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191905.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206957. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191904.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206958. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191903.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206959. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191902.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206960. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191901.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206961. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191900.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206962. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191899.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206963. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191898.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206964. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191897.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206965. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191896.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206966. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191895.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206967. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191894.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206968. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191893.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206969. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191892.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206970. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191891.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206971. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191890.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206972. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191889.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206973. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191888.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206974. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191887.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206975. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191886.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206976. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191885.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206977. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191884.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206978. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191883.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206979. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191882.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206980. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191881.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206981. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191880.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206982. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191879.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206983. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191878.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206984. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191877.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206985. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191876.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206986. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191875.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206987. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191874.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206988. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191873.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206989. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191872.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206990. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191871.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206991. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191870.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206992. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191869.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206993. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191868.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206994. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191867.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206995. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191866.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206996. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191865.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206997. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191864.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206998. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191863.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB206999. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191862.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207000. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191861.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207001. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191860.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207002. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191859.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207003. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191858.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207004. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191857.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207005. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191856.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207006. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191855.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207007. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191854.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207008. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191853.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207009. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191852.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207010. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191851.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207011. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191850.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207012. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191849.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207013. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191848.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207014. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191847.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207015. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191846.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207016. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191845.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207017. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191844.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207018. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191843.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207019. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191842.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207020. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191841.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207021. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191840.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207022. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191839.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207023. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191838.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207024. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191837.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207025. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191836.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207026. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191835.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207027. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191834.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207028. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191833.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207029. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191832.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207030. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191831.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207031. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191830.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207032. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191829.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207033. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191828.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207034. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191827.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207035. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191826.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207036. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191825.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207037. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191824.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207038. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191823.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207039. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191822.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207040. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191821.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207041. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191820.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207042. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191819.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207043. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191818.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207044. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191817.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207045. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191816.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207046. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191815.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207047. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191814.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207048. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191813.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207049. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191812.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207050. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191811.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207051. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191810.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207052. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191809.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207053. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191808.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207054. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191807.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207055. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191806.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207056. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191805.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207057. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191804.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207058. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191803.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207059. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191802.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207060. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191801.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207061. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191800.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207062. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191799.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207063. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191798.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207064. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191797.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207065. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191796.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207066. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191795.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207067. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191794.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207068. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191793.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207069. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191792.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207070. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191791.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207071. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191790.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207072. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191789.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207073. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191788.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207074. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191787.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207075. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191786.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207076. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191785.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207077. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191784.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207078. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191783.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207079. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191782.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207080. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191781.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207081. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191780.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207082. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191779.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207083. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191778.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207084. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191777.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207085. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191776.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207086. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191775.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207087. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191774.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207088. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191773.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207089. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191772.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207090. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191771.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207091. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191770.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207092. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191769.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207093. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191768.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207094. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191767.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207095. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191766.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207096. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191765.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207097. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191764.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207098. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191763.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207099. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191762.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207100. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191761.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207101. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191760.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207102. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191759.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207103. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191758.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207104. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191757.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207105. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191756.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207106. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191755.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207107. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191754.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207108. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191753.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207109. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191752.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207110. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191751.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207111. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191750.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207112. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191749.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207113. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191748.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207114. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191747.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207115. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191746.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207116. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191745.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207117. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191744.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207118. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191743.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207119. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191742.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207120. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191741.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207121. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191740.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207122. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191739.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207123. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191738.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207124. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191737.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207125. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191736.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207126. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191735.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207127. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191734.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207128. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191733.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207129. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191732.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207130. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191731.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207131. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191730.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207132. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191729.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207133. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191728.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207134. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191727.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207135. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191726.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207136. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191725.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207137. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191724.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207138. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191723.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207139. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191722.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207140. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191721.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207141. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191720.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207142. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191719.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207143. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191718.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207144. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191717.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207145. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191716.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207146. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191715.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207147. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191714.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207148. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191713.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207149. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191712.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207150. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191711.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207151. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191710.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207152. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191709.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207153. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191708.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207154. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191707.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207155. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191706.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207156. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191705.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207157. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191704.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207158. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191703.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207159. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191702.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207160. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191701.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207161. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191700.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207162. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191699.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207163. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191698.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207164. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191697.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207165. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191696.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207166. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191695.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207167. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191694.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207168. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191693.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207169. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191692.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207170. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191691.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207171. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191690.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207172. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191689.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207173. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191688.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207174. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191687.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207175. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191686.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207176. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191685.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207177. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191684.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207178. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191683.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207179. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191682.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207180. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191681.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207181. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191680.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207182. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191679.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207183. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191678.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207184. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191677.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207185. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191676.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207186. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191675.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207187. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191674.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207188. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191673.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207189. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191672.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207190. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191671.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207191. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191670.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207192. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191669.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207193. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191668.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207194. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191667.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207195. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191666.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207196. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191665.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207197. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191664.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207198. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191663.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207199. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191662.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207200. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191661.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207201. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191660.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207202. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191659.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207203. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191658.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207204. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191657.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207205. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191656.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207206. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191655.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207207. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191654.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207208. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191653.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207209. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191652.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207210. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191651.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207211. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191650.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207212. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191649.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207213. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191648.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207214. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191647.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207215. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191646.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207216. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191645.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207217. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191644.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207218. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191643.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207219. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191642.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207220. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191641.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207221. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191640.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207222. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191639.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207223. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191638.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207224. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191637.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207225. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191636.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207226. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191635.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207227. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191634.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207228. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191633.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207229. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191632.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207230. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191631.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207231. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191630.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207232. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191629.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207233. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191628.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207234. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191627.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207235. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191626.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207236. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191625.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207237. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191624.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207238. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191623.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207239. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191622.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207240. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191621.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207241. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191620.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207242. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191619.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207243. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191618.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207244. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191617.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207245. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191616.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207246. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191615.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207247. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191614.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207248. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191613.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207249. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191612.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207250. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191611.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207251. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191610.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207252. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191609.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207253. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191608.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207254. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191607.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207255. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191606.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207256. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191605.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207257. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191604.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207258. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191603.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207259. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191602.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207260. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191601.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207261. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191600.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207262. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191599.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207263. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191598.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207264. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191597.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207265. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191596.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207266. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191595.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207267. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##
NW_004191594.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy andPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4xPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: SangerPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to KB207268. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Genome Sequencing Centers for Infectious Diseases (GSCID) program. ##Genome-Assembly-Data-START## Assembly Method       :: Celera Assembler v. 3 Assembly Name         :: EIA2 v2 Genome Coverage       :: 4x Sequencing Technology :: Sanger ##Genome-Assembly-Data-END##